Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Spitznagel

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Journal of HIV/AIDS & Social Services|March 29, 2014
Characterizing HIV medication adherence for virologic success among individuals living with HIV/AIDS: Experience with the CNS HIV Antiretroviral Therapy Effects Research (CHARTER) cohortB Biswas, E Spitznagel, A C Collier, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 1, 1994
Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operationsG J Despotis, A L Summerfield, J H Joist, et al.
Thrombosis and Haemostasis|December 1, 1996
More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACTG J Despotis, J H Joist, C W Hogue, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 1, 1995
The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operationG J Despotis, J H Joist, C W Hogue, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|February 14, 2015
Ecological momentary assessment of tinnitus using smartphone technology: a pilot studyMichael B Wilson, Dorina Kallogjeri, Conor N Joplin, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 1, 1993
Symptomatic cytomegalovirus infection in renal transplant recipients given either Minnesota antilymphoblast globulin (MALG) or OKT3 for rejection prophylaxisT C Bailey, W G Powderly, G A Storch, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Journal of HIV/AIDS & Social Services|March 29, 2014
Characterizing HIV medication adherence for virologic success among individuals living with HIV/AIDS: Experience with the CNS HIV Antiretroviral Therapy Effects Research (CHARTER) cohortB Biswas, E Spitznagel, A C Collier, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 1, 1994
Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operationsG J Despotis, A L Summerfield, J H Joist, et al.
Thrombosis and Haemostasis|December 1, 1996
More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACTG J Despotis, J H Joist, C W Hogue, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 1, 1995
The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operationG J Despotis, J H Joist, C W Hogue, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|February 14, 2015
Ecological momentary assessment of tinnitus using smartphone technology: a pilot studyMichael B Wilson, Dorina Kallogjeri, Conor N Joplin, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 1, 1993
Symptomatic cytomegalovirus infection in renal transplant recipients given either Minnesota antilymphoblast globulin (MALG) or OKT3 for rejection prophylaxisT C Bailey, W G Powderly, G A Storch, et al.
Pageof 4